Top

Journal of General Internal Medicine

Published in:

01-01-2021 | Original Research

Comparison of Discounted and Undiscounted Cash Prices for Cardiovascular Medications by Type of US Community Pharmacy

Authors: Minji Hong, PharmD Candidate, Natalia Shcherbakova, PhD

Published in: Journal of General Internal Medicine | Issue 1/2021

Abstract

Background

Cash prices for prescription drugs vary among community pharmacies in the USA. GoodRx is a discount platform that provides coupons for use in community pharmacies without a membership requirement. Analytical pharmacy is a new type of pharmacy that tests drugs before dispensing to verify medication quality.

Objective

To compare undiscounted and GoodRx-discounted cash prices for common cardiovascular (CV) drugs by pharmacy type.

Design

A cross-sectional study.

Setting

GoodRx-discounted and GoodRx-undiscounted cash price data; analytical pharmacy cash price data (all data collected in July 2020).

Measurements

GoodRx cash price data for 30 units of 41 generic and 16 brand-name common cardiovascular medications at mass merchandiser, regional supermarket, two national chains, and analytical pharmacy (only one of its kind in the USA).

Results

The average (SD) undiscounted generic CV medication cash price was $42.41 (44.1). The average GoodRx-discounted generic CV medication cash prices were $11.01 (8.6), $9.88 (6.7), $17.85 (10.5), and $21.73 (14.1) in mass merchandiser, supermarket, and two national chain pharmacies, respectively. The average generic CV medication cash price was $20.84 (25.7) at the analytical pharmacy. The average (SD) undiscounted brand-name CV medication cash price was $368.33 (127.00). The average GoodRx-discounted brand-name CV medication cash prices were $269.16 (118.1), $258.84 (108.6), $270.28 (118.4), and $274.60 (122.50) for mass merchandiser, supermarket, and two national chain pharmacies, respectively. The average (SD) brand-name CV medication cash price was $365.12 (116.20) at the analytical pharmacy.

Conclusions

GoodRx-discounted cash prices of generic CV medications were significantly lower than undiscounted cash prices at supermarket, mass merchandiser, and national chain pharmacies. Analytical pharmacy cash prices too were significantly lower than traditional pharmacy undiscounted cash prices. GoodRx-discounted prices for brand-name CV medications did not differ significantly from undiscounted cash prices and between pharmacy types.

Martin CB, Hales CM, Gu Q, Ogden CL. Prescription Drug Use in the United States, 2015-2016. NCHS Data Brief. 2019:1-8

Hales CM, Servais J, Martin CB, Kohen D. Prescription Drug Use Among Adults Aged 40-79 in the United States and Canada. NCHS Data Brief. 2019:1-8

Lee S, Jiang L, Dowdy D, Hong YA, Ory MG. Attitudes, Beliefs, and Cost-Related Medication Nonadherence Among Adults Aged 65 or Older With Chronic Diseases. Prev Chronic Dis. 2018;15:E148. https://doi.org/10.5888/pcd15.180190CrossRefPubMedPubMedCentral

Beer L, Tie Y, Weiser J, Shouse RL. Nonadherence to Any Prescribed Medication Due to Costs Among Adults with HIV Infection - United States, 2016-2017. MMWR Morb Mortal Wkly Rep. 2019;68:1129-33. https://doi.org/10.15585/mmwr.mm6849a1CrossRefPubMedPubMedCentral

Zhang JX, Lee JU, Meltzer DO. Risk factors for cost-related medication non-adherence among older patients with diabetes. World J Diabetes. 2014;5:945-50. https://doi.org/10.4239/wjd.v5.i6.945CrossRefPubMedPubMedCentral

Lewey J, Gagne JJ, Franklin J, Lauffenburger JC, Brill G, Choudhry NK. Impact of High Deductible Health Plans on Cardiovascular Medication Adherence and Health Disparities. Circ Cardiovasc Qual Outcomes. 2018;11:e004632. https://doi.org/10.1161/CIRCOUTCOMES.118.004632CrossRefPubMed

Luo J, Kulldorff M, Sarpatwari A, Pawar A, Kesselheim AS. Variation in Prescription Drug Prices by Retail Pharmacy Type: A National Cross-sectional Study. Ann Intern Med. 2019;171:605-11. https://doi.org/10.7326/M18-1138CrossRefPubMed

Pasalic D, Lingineni RK, Cloft HJ, Kallmes DF. Nationwide price variability for an elective, outpatient imaging procedure. J Am Coll Radiol. 2015;12:444-52. https://doi.org/10.1016/j.jacr.2014.11.024CrossRefPubMed

Qato DM, Zenk S, Wilder J, Harrington R, Gaskin D, Alexander GC. The availability of pharmacies in the United States: 2007-2015. PLoS One. 2017;12:e0183172. https://doi.org/10.1371/journal.pone.0183172CrossRefPubMedPubMedCentral

10.

FDA Has Improved Its Foreign Drug Inspection Program, but Needs to Assess the Effectiveness and Staffing of Its Foreign Offices. United States Government Accountability Office; https://www.gao.gov/assets/690/681689.pdf; Accessed May 21, 2020.

11.

Lever HM. A Physician’s Perspective on Generic Drug Quality. J Manag Care Spec Pharm. 2020;26:592-3. https://doi.org/10.18553/jmcp.2020.26.5.592CrossRefPubMed

12.

Medicine Use and Spending in the U.S. A Review of 2018 and Outlook to 2023 The IQVIA Institute; https://www.iqvia.com/insights/the-iqvia-institute/reports/medicine-use-and-spending-in-the-us-a-review-of-2018-and-outlook-to-2023; 2019; p. 48. Accessed May 24, 2020

13.

Fuentes AV, Pineda MD, Venkata KCN. Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice. Pharmacy (Basel). 2018;6. https://doi.org/10.3390/pharmacy6020043

14.

Valisure Sign Up. https://shop.valisure.com/signup; Accessed May 21, 2020.

15.

National Average Drug Aquisition Cost. https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-National-Average-Drug-Acquisition-Cost-/a4y5-998d; Accessed May 24, 2020.

16.

Arora S, Sood N, Terp S, Joyce G. The price may not be right: the value of comparison shopping for prescription drugs. Am J Manag Care. 2017;23:410-5.PubMed

17.

Mishra K, Bukavina L, Mahran A, et al. Variability in Prices for Erectile Dysfunction Medications-Are All Pharmacies the Same? J Sex Med. 2018;15:1785-91. https://doi.org/10.1016/j.jsxm.2018.10.011CrossRefPubMed

18.

White CM. Generic Drugs Not as Safe as FDA Wants You to Believe. Ann Pharmacother. 2020;54:283-6. https://doi.org/10.1177/1060028019881692CrossRefPubMed

19.

Gibson R, Singh J. China Rx: Exposing the Risks of America’s Dependence on China for Medicine. Guilford, CT: Prometheus Books; 2018.

20.

White CM. Understanding and Preventing (N-Nitrosodimethylamine) NDMA Contamination of Medications. Ann Pharmacother. 2020;54:611-4. https://doi.org/10.1177/1060028019892222CrossRefPubMed

21.

FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan). https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-angiotensin-ii-receptor-blocker-arb-recalls-valsartan-losartan; 2019 Accessed May 24, 2020

22.

Valisure Division of Dockets Management, Food and Drug Administration. Valisure citizen petition on ranitidine.; https://www.valisure.com/wp-content/uploads/Valisure-Ranitidine-FDA-Citizen-Petition-v4.12.pdf; Accessed May 24, 2020.

23.

Valisure Certificate of Analysis. https://www.valisure.com/analysis/; Accessed May 24, 2020.

24.

GoodRx Saves Money on Meds-It Also Shares Data With Google, Facebook, and Others. https://www.consumerreports.org/health-privacy/goodrx-shares-users-health-data-with-google-facebook-others/; Accessed May 19, 2020.

25.

Esteve A. The business of personal data: Google, Facebook, and privacy issues in the EU and the USA. Int Data Privacy Law. 2017;7:36-47.CrossRef

26.

Grundy Q, Chiu K, Bero L. Commercialization of User Data by Developers of Medicines-Related Apps: a Content Analysis. J Gen Intern Med. 2019;34:2833-41. https://doi.org/10.1007/s11606-019-05214-0CrossRefPubMedPubMedCentral

27.

Aitken M. Understanding the Pharmaceutical Value Chain. Pharm Policy Law 2016;18:55-66. https://doi.org/10.3233/PPL-160432CrossRef

Title: Comparison of Discounted and Undiscounted Cash Prices for Cardiovascular Medications by Type of US Community Pharmacy
Authors: Minji Hong, PharmD Candidate
Natalia Shcherbakova, PhD
Publication date: 01-01-2021
Publisher: Springer International Publishing
Published in: Journal of General Internal Medicine / Issue 1/2021
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-020-06149-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Design

Setting

Measurements

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Rallying Against Racism: Hospitals Join the Fight for Racial Justice

Population Segmentation Based on Healthcare Needs: Validation of a Brief Clinician-Administered Tool

National Well-Being Measures Before and During the COVID-19 Pandemic in Online Samples

Impact of Unannounced Standardized Patient Audit and Feedback on Care, Documentation, and Costs: an Experiment and Claims Analysis

Extensive Underreported Exposure to Ketamine Among Electronic Dance Music Party Attendees

Translating Evidence into Practice: ACOs’ Use of Care Plans for Patients with Complex Health Needs

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials